William Carion
Internal Medicine · Shelby Township, MINPI 1558456251
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $572 and has fallen 88.3% since, to $67 in 2023.
Across 84 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$202
- Novartis$134
- Amgen$118
- Novo Nordisk$90
- Lilly USA, LLC$88
- Boehringer Ingelheim$83
- plus $553 from 18 others
What the payments were for
- Food & beverage$1,269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Novartis | 7 | $134 |
| Amgen | 9 | $118 |
| Novo Nordisk | 7 | $90 |
| Lilly USA, LLC | 6 | $88 |
| Boehringer Ingelheim | 6 | $83 |
| AbbVie | 5 | $79 |
| Pfizer | 5 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Johnson & Johnson | 4 | $45 |
| Amarin Pharma, Inc. | 3 | $37 |
| GSK | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Almatica Pharma LLC | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $23 |
| Abbott | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$1,269 in reported general payments places this provider in the 75th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Shelby Township
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
- Mohamad HatahetWaterford$352K
- A FendrickAnn Arbor$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.